Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 505-515

  Park, Hee Sun ^a   Kim, Keun Hwa ^a   Jang, Sunhyae ^a   Park, Ji Won ^a   Cha, Hye Rim ^a   Lee, Jeong Eun ^a   Kim, Ju Ock ^a   Kim, Sun Young ^a   Lee, Choong Sik ^a   Kim, Joo Pyung ^b   Jung, Sung Soo ^a  

^a Chungnam National University   (South Korea)

^b Nanochemical Incorporation ^*

Author keywords

Allergic airway disease; NF B; Oxidative stress; Silver nanoparticles

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; TRANSCRIPTION FACTOR RELA; INTERLEUKIN DERIVATIVE; MESSENGER RNA; METAL NANOPARTICLE; RELA PROTEIN, MOUSE; SILVER;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRONCHITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HYPERSENSITIVITY REACTION; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LUNG LAVAGE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ANIMAL; ASTHMA; C57BL MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; NANOMEDICINE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT ALLERGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

MURINAE; MUS;

ANIMALS; ASTHMA; BASE SEQUENCE; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKINS; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; RNA, MESSENGER; SILVER; TRANSCRIPTION FACTOR RELA;

EID: 79952118660     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s11664     Document Type: Article

References (67)

1. Tsuji JS, Maynard AD, Howard PC, et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci. 2006;89:42-50.
2. Heger M. Safety of new bacteria-killing coating questioned. Scienceline. 2008 Apr 21. http://www.livescience.com/technology/080421-silvernano.html
3. El-Sayed MA. Small is different: shape-, size-, and compositiondependent properties of some colloidal semiconductor nanocrystals. Acc Chem Res. 2004;37:326-333.
4. Ho CM, Yu WY, Che CM. Ruthenium nanoparticles supported on hydroxyapatite as an efficient and recyclable catalyst for cis- dihydroxylation and oxidative cleavage of alkenes. Angew Chem Int Ed. 2004;43:3303-3307.
5. Lang H, May RA, Iversen BL, Chandler BD. Dendrimer-encapsulated nanoparticle precursors to supported platinum catalysts. J Am Chem Soc. 2003;125:14832-14836.
6. Lewis LN. Chemical catalysis by colloids and clusters. Chem Rev. 1993; 93:2693-2730.
7. Nicewarner-Pena SR, Freeman RG, Reiss BD, et al. Submicrometer metallic barcodes. Science. 2001;294:137-141.
8. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science. 1997;277:1078-1081.
9. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res. 2007;41:615-626.
10. Huang B, Zhang J, Hou J, Chen C. Free radical scavenging efficiency of nano-Se in vitro. Free Radic Biol Med. 2003;35:805-813.
11. Kim J, Takahashi M, Shimizu T, et al. Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans. 2008; 129:322-331.
12. Modak SM, Fox CL Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol. 1973; 22:2391-2404.
13. Hanif J, Tasca RA, Frosh A, Ghufoor K, Stirling R. Silver nitrate: histological effects of cautery on epithelial surfaces with varying contact times. Clin Otolaryngol Allied Sci. 2003;28:368-370.
14. Antonangelo L, Vargas FS, Teixeira LR, et al. Pleurodesis induced by talc or silver nitrate evaluation of collagen and elastic fibers in pleural remodeling. Lung. 2006;184:105-111.
15. Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM. Silver nanoparticles fabricated in herpes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun. 2005;40:5059-5061.
16. Tian J, Wong K, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem. 2007;2:129-136.
17. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Rep Reg. 2002;10:141-151.
18. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emergin discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
19. Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanoparticle Res. 2005;7:587-614.
20. Lee KS, Kim SR, Park SJ, et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol. 2006;118:120-127.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551-560.
23. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy. 2000;30:79-85.
24. Kay AB. Asthma and inflammation. J Allergy Clin Immunol. 1991; 87:893-910.
25. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720-1745.
26. Dworski R. Oxidant stress in asthma. Thorax. 2000;55:S51-S53.
27. Calhoun WJ, Reed HE, Moest DR, Stevens CA. Enhanced superoxide production by alveolar macrophages and airspace cells, airway inflammation, and alveolar macrophage density changes follow segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis. 1992;145:317-325.
28. Calhoun WJ, Bush RK. Enhanced reactive oxygen species metabolism of airspace cells and airway inflammation following antigen challenge in human asthma. J Allergy Clin Immunol. 1990;86:306-313.
29. Schauer U, Leinhaas C, Jäger R, Rieger CH. Enhanced superoxide generation by eosinophils from asthmatic children. Int Arch Allergy Appl Immunol. 1991;96:317-321.
30. Teramoto S, Shu CY, Ouchi Y, Fukuchi Y. Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma. 1996;33:149-155.
31. Henricks PA, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther. 2001;14:409-420.
32. Hulsmann AR, Raatgeep HR, den Hollander JC, et al. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med. 1994;149:519-525.
33. Cortijo J, Marti-Cabrera M, de la Asuncion JG, et al. Contraction of human airways by oxidative stress protection by N-acetylcysteine. Free Radic Biol Med. 1999;27:392-400.
34. Sadeghi-Hashjin G, Folkerts G, Henricks PA, et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med. 1996;153:1697-1701.
35. Adam L, Bouvier M, Jones TL. Nitric oxide modulates beta(2)- adrenergic receptor palmitoylation and signaling. J Biol Chem. 1999;274:26337-26343.
36. Owen S, Pearson D, Suarez-Mendez V, O'Driscoll R, Woodcock A. Evidence of free-radical activity in asthma. N Engl J Med. 1991;325: 586-587.
37. Krishna MT, Madden J, Teran LM, et al. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J. 1998;11:1294-1300.
38. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
39. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405-455.
40. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87: 13-20.
41. Gilmore TD. The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene. 1999;18:6842-6844.
42. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336: 1066-1071.
43. Barnes PJ, Adcock IM. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997;18:46-50.
44. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen species intermediates as apparently widely used messengers in the activation of the NF?B transcription factor and HIV-1. EMBO J. 1991;10:2247-2258.
45. Henderson WR Jr, Chi EY, Teo JL, Nguyen C, Kahn M. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol. 2002;169:5294-5299.
46. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax. 1998;53:601-612.
47. Shang F, Gong X, Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem. 1997;272:23086-23093.
48. Ginn-Pease ME, Whisler RL. Optimal NF-?B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun. 1996;226:695-702.
49. Stutz AM, Woisetschlager M. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J Immunol. 1999;163:4383-4391.
50. Mori A, Kaminuma O, Mikami T, et al. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J Allergy Clin Immunol. 1999; 103:S429-S436.
51. Lee YC, Lee KS, Park SJ, et al. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid. FASEB J. 2004; 18:1917-1919.
52. Schenk H, Klein M, Erdbrugger W, Dröge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci U S A. 1994; 91:1672-1676.
53. Jun DY, Chae HZ, Rhee SG, Jeang KT. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J Biol Chem. 1997;27:30952-30961.
54. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol. 1997;52:465-672.
55. Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G, Goldman M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol. 1999;162:2569-2574.
56. Harper R, Wu K, Chang MM, et al. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am J Respir Cell Mol Biol. 2001;25:178-185.
57. Bhol KC, Schechter PJ. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci. 2007;52:2732-2742.
58. Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol. 2004;29:282-287.
59. Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol. 2005;152:1235-1242.
60. Boucher W, Stern JM, Kotsinyan V, et al. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J Urol. 2008;179:1598-1602.
61. Chen D, Xi T, Bai J. Biological effects induced by nanosilver particles. Biomed Mater. 2007;2:S126-S128.
62. Shin SH, Ye MK, Kim HS, Kang HS. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol. 2007;7:1813-1818.
63. Kim SB, Ozawa T, Tao H, Umezawa Y. A proinflammatory cytokine sensor cell for assaying inflammatory activities of nanoparticles. Anal Biochem. 2007;362:148-150.
64. Gozal E, Ortiz LA, Zou XY, Burow ME, Lasky JA, Friedman M. Silica-induced apoptosis in murine macrophage: involvement of tumor necrosis factor-a and nuclear factor-κB activation. Am J Respir Cell Mol Biol. 2002;27:91-98.
65. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95-101.
66. Danilczuk M, Lund A, Saldo J, Yamada H, Michalik J. Conduction electron spin resonance of small silver particles. Spectrochim Acta A Mol Biomol Spectrosc. 2006;63:189-191.
67. Cha K, Hong HW, Choi YG, et al. Compariton of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol Lett. 2008;30:1893-1899.